Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Annals of the Rheumatic Diseases
|
October 14, 2015
Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study
J Montoya, N B Matta, P Suchon, et al.
Journal of Clinical Monitoring and Computing
|
September 7, 2015
Intraoperative non invasive intracranial pressure monitoring during pneumoperitoneum: a case report and a review of the published cases and case report series
C Robba, S Bacigaluppi, D Cardim, et al.
The Journal of Hospital Infection
|
August 15, 2008
Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK
D A Enoch, C Summers, N M Brown, et al.
Leukemia & Lymphoma
|
August 11, 2011
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia
Mark C Lanasa, Patricia H Davis, Michael Datto, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Annals of the Rheumatic Diseases
|
October 14, 2015
Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study
J Montoya, N B Matta, P Suchon, et al.
Journal of Clinical Monitoring and Computing
|
September 7, 2015
Intraoperative non invasive intracranial pressure monitoring during pneumoperitoneum: a case report and a review of the published cases and case report series
C Robba, S Bacigaluppi, D Cardim, et al.
The Journal of Hospital Infection
|
August 15, 2008
Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK
D A Enoch, C Summers, N M Brown, et al.
Leukemia & Lymphoma
|
August 11, 2011
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia
Mark C Lanasa, Patricia H Davis, Michael Datto, et al.
Page
of 4